Sotac Pharmaceuticals Ltd
Ticker: SOTAC
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
125.00
Market Cap
138.13
Debt/Equity
0.7480
ROE %
14.886
PB
2.3643
Promoter %
72.851
Pledge %
0.000
1Y Rev Growth %
-3.288
5Y Rev Growth %
NP Margin %
7.949
NP Margin 5Y Avg %
Trading Reference
1M Return %
1.543
6M Return %
0.321
1Y Return %
-13.194
% Away 52W High
21.880
% Away 52W Low
41.965
Daily Volume
3600
Investment Verdict
Buy
Score 77/100 · Position size: 40%
Long-term fundamentals are strong. Suitable for investors with a 1–3+ year horizon.
Trading Verdict
Avoid
Score 22/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Sotac Pharmaceuticals Ltd is currently trading near its support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a potential for significant upside. However, if it falls below the support, downside risks increase.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
R
Rajshree Sugars & Chemicals Ltd
Rajshree Sugars & Chemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
S
SNL Bearings Ltd
SNL Bearings Ltd shows potential in a stable industry, but faces challenges in profitability and valuation metrics.
View details
K
Keynote Financial Services Ltd
Keynote Financial Services Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
S
Sheetal Universal Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Shri Hare-Krishna Sponge Iron Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
U
United Heat Transfer Ltd
United Heat Transfer Ltd faces several challenges, including inconsistent growth and market sentiment issues, making it a risky investment at this time.
View details
B
Baid Finserv Ltd
Baid Finserv Ltd shows potential for growth in a promising sector, but faces challenges in profitability and valuation metrics. Investors should proceed with caution.
View details
S
Shah Alloys Ltd
Shah Alloys Ltd presents a risky investment opportunity due to inconsistent growth and weak market sentiment.
View details
G
Gujarat Toolroom Ltd
Gujarat Toolroom Ltd presents several risks with inconsistent growth and profitability metrics, alongside weak market sentiment.
View details
I
Indian Phosphate Ltd
Indian Phosphate Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
View details
S
SecMark Consultancy Ltd
While SecMark Consultancy Ltd operates in a potentially future-ready sector, its inconsistent growth and profitability metrics raise concerns. The valuation appears stretched, and governance issues need addressing.
View details
S
Sameera Agro and Infra Ltd
Sameera Agro and Infra Ltd presents a risky investment due to inconsistent growth and profitability metrics, despite some potential in the sector.
View details
Y
Yuvraaj Hygiene Products Ltd
Yuvraaj Hygiene Products Ltd shows potential for growth in a favorable sector, but faces challenges in valuation and governance.
View details
R
Royal Sense Ltd
Royal Sense Ltd shows potential but faces challenges in profitability and market sentiment.
View details
S
Suryalata Spinning Mills Ltd
Suryalata Spinning Mills Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Surat Trade and Mercantile Ltd
The stock presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
Business Overview
Sotac Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to developing innovative healthcare solutions. Catering primarily to healthcare providers and patients, Sotac focuses on enhancing the quality of life through effective medications. The company's commitment to research and development ensures a robust pipeline of products that address critical health challenges. With a strong emphasis on quality and compliance, Sotac stands out as a trusted partner in the healthcare industry.
- Leading player in the Indian pharmaceutical sector
- Innovative healthcare solutions for patients and providers
- Strong focus on research and development
- Commitment to quality and compliance
- Addressing critical health challenges effectively
Investment Thesis
Sotac Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. These factors position the company for robust long-term performance in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Growing digital services segment opens new revenue streams and market opportunities.
- Attractive valuation metrics compared to industry peers suggest potential for price appreciation.
- Solid fundamentals and strategic initiatives support sustainable growth.
- Positive market sentiment and increasing demand for healthcare solutions bolster prospects.
Opportunity vs Risk
Opportunities
- Growing demand for innovative therapies
- Strong pipeline of new drugs
- Strategic partnerships with healthcare providers
- Expansion into emerging markets
Risks ⚠️
- Regulatory approval delays
- High competition in pharmaceuticals
- R&D costs may escalate
- Market volatility affecting stock price
Peer Perspective
Sotac Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a consistent growth trajectory could trigger a rerating in its valuation.
Future Outlook
Sotac Pharmaceuticals Ltd is well-positioned for growth, driven by its innovative pipeline and market strategies; however, successful execution and stringent cost control will be essential to realize its full potential in the coming years.
AI FAQs for Retail Users
- Q: What does Sotac Pharmaceuticals Ltd do?A: Sotac Pharmaceuticals Ltd focuses on developing and manufacturing pharmaceutical products for various therapeutic areas.
- Q: Is Sotac Pharmaceuticals Ltd a publicly traded company?A: Yes, Sotac Pharmaceuticals Ltd is listed on the stock exchanges in India.
- Q: What factors can affect the stock price of Sotac Pharmaceuticals Ltd?A: Factors include market conditions, company performance, regulatory changes, and industry trends.
- Q: How can I invest in Sotac Pharmaceuticals Ltd?A: You can invest by purchasing shares through a registered stockbroker or online trading platform.
- Q: What is the risk of investing in Sotac Pharmaceuticals Ltd?A: Like all stocks, investing in Sotac Pharmaceuticals Ltd carries risks, including market volatility and company-specific challenges.
📊 Stock Investment Checklist (100 Points)
Sotac Pharmaceuticals Ltd • Updated: 2025-09-18 09:48:32
-
8BusinessHighPharmaceutical sector is growing with increasing healthcare demands.
-
10GrowthHighRevenue growth has been consistent, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is not consistently strong.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
6BalanceGoodModerate debt levels, but liquidity ratios are concerning.
-
7GovernanceHighPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
1TechnicalsLowMarket sentiment is weak with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Sotac Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks and market sentiment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100